baber/WOPTO huggingface dataset:
Patent CA-2451525-A1 (CA)
Inventor: FRIEDL ARNO
IPC: A61K31/5377
Filed: 2002-06-10
Abstract: L'invention concerne de nouvelles imidazotriazines de la formule générale (I), leur procédé de production et leur utilisation pour la production de médicaments destinés au traitement et/ou à la prophylaxie de maladies neurodégéneratives, notamment de la maladie de Parkinson.
Patent CA-2452274-A1 (CA)
Title: System and method of testing and evaluating mathematical functions
Inventor: ENENKEL ROBERT F
IPC: G06F17/18
Filed: 2003-12-03
Abstract: The present invention provides a system and method for systematic random testing of single- or double-precision, one- or two-variable, scalar or vector mathematical functions against a known higher precision reference mathematical library or to the result of an arbitrary precision mathematical package. The systematic random testing of mathematical functions is performed across the entire floating-point range or a test interval defined therein, including denormalized numbers, with random test arguments appropriately distributed over the test interval. By ensuring the density of coverage of random test arguments across the test interval by comparison against a statistical model and identifying the exception behavior of the mathematical function, an accurate picture of the performance and accuracy of the mathematical function can be assessed.
Patent CA-2453277-A1 (CA)
Inventor: PODMORE JONATHAN L
IPC: A61F2/24
Filed: 2002-04-11
Abstract: L'invention concerne un procédé avec effraction minimale de réalisation d'une annuloplastie. Selon un aspect de l'invention, un procédé de réalisation d'une annuloplastie consiste à accéder à un ventricule gauche du coeur afin de lui fournir un élément de plication discret, et accoupler l'élément de plication aux tissus situés à proximité d'une valvule mitrale du coeur. Le couplage de l'élément de plication consiste à entraîner ce dernier à assembler une portion de tissu afin de créer une plication. Dans un autre mode de réalisation, le procédé consiste à accéder au ventricule gauche du coeur afin de lui fournir l'élément de plication, l'accès au ventricule gauche s'effectuant au moyen d'un système de cathéter.
Patent CA-2453588-A1 (CA)
Title: Personalised profile update
Inventor: THINT MARCUS
IPC: G06F17/30
Filed: 2003-12-16
Abstract: A method and apparatus are provided to infer, from monitored user activity, appropriate updates to a respective user profile. The method and apparatus are suitable for use with applications programs that customise services based upon data and attributes stored in a user profile. The apparatus is arranged to personalise various aspects of a preferred profile updating process on the basis of stored user preferences;  applying meta-rules rules to apply those user preferences to the definition of a set of personalised rule weights to be applied in a fuzzy inference process that infers profile updates by applying fuzzy rules and fuzzy sets to the analysis of event statistics derived from the results of user monitoring. The personalised rule weights are applied to selectively adjust the effect of particular fuzzy rules. In addition, mapping of event statistics to fuzzy rule premises in the fuzzy inference process may be personalised through the use of user-defined fuzzy sets.
Patent CA-2456345-A1 (CA)
Inventor: TROWBRIDGE GEOFF
IPC: E04D15/02
Filed: 2004-01-28
Abstract: The process of adhering asphaltic roofing tiles to a roof deck by covering the tiles on the deck with a heat blanket capable of generating a temperature of at least the cure temperature of the tiles thereby sealing the tiles to the deck.
Patent CA-2458091-A1 (CA)
Inventor: SONNEVELD SUSANNE
IPC: A23L7/00
Filed: 2004-02-19
Abstract: A food product, suitable for a controlled carbohydrate diet comprises identifiable pieces of cereal-like core held together with a binding agent, with the product being 30% or less in digestible carbohydrate. The product may be consumed as part of a weight loss or maintenance program; or as nutritional support in any case where escessive blood sugar is to be avoided, such as in subjects suffering from excess weight or obesity, hyperglycemia, insulin resistance and types I and I diabetes.
Patent CA-2459181-A1 (CA)
Title: Stretch releasing adhesive tape article with flexible cover
Inventor: HAMERSKI MICHAEL D
IPC: C09J7/20
Filed: 2002-07-22
Abstract: An article for use with a stretch releasing adhesive tape strip having a non-adhesive pull tab includes a unitary attachment member (218) having a base plate portion (220) sized to overlay the entire stretch releasing adhesive tape strip. The base plate portion (220) includes a first portion (224) that overlays the adhesive portion of tape strip and a flexible cover portion (226) that overlays the non-adhesive pull tab (212). A user can manually urge the cover portion (226) away from the pull tab (212), thereby accessing the pull tab (212) and allowing the user to stretch remove the tape strip from the unitary attachment member and a substrate to which it is adhered.
Patent CA-2459511-A1 (CA)
Inventor: RYAN ALLISON MARIE
IPC: A41D19/00
Filed: 2002-10-17
Abstract: L'invention concerne un gant à mouler tricoté qui, lorsqu'il est mouillé, confère à une surface de travail collante une propriété supprimant la tendance au collant. Le gant comprend un fil tricoté d'un matériau de base et d'un matériau hydrosoluble ayant un point de dissolution bas ou d'un matériau de base et d'un matériau gonflable dans l'eau. Le gant à mouler tricoté peut être porté sur un gant d'examen standard.
Patent CA-2459982-A1 (CA)
Title: Method and shaped product formed from polymerizable dental material and fluorescing agent
Inventor: LICHKUS ANDREW M
IPC: A61K6/00
Filed: 2004-03-08
Abstract: The invention provides a method of making a dental appliance by including fluorescing agent the surfaces of dental appliances are visually identifiable.
Patent CA-2460377-A1 (CA)
Title: Therapeutic vaccination method, mutated peptides of hiv reverse transcriptase and their use for vaccination and diagnostic purposes
Inventor: AUTRAN BRIGITTE
IPC: A61K39/00
Filed: 2001-09-14
Abstract: The invention concerns treatment of infectious and tumoral pathologies comprising a anti-infective and/or anti-tumoral chemotherapeutic treatment phase inducing resistance mutations and a therapeutic vaccination phase directed against said resistance mutations and the agents used in said treatment. More particularly, the invention concerns peptides of 8 to 80 amino acids of the HIV reverse transcriptase sequence and comprising at least a mutation with respect to said wild sequence of said enzyme, mutation induced in response to treatments by nucleoside and non-nucleoside analogues of the HIV reverse transcriptase. The invention also concerns a pharmaceutical composition or vaccine based on said peptides, for inducing an immune response specific of said mutated sequences and for enhancing or prolonging the efficiency of treatments with nucleoside or non-nucleoside analogues of the HIV reverse transcriptase. The invention further concerns epitopes derived from said peptide sequences to evaluate the specific immune response following the vaccine injection.
Patent CA-2463462-A1 (CA)
Title: Method for producing ultrafine dispersion water of noble metal ultrafine particles
Inventor: SUZUKI KAZUAKI
IPC: A61K35/02
Filed: 2002-10-11
Abstract: By using an apparatus composed of a high-voltage discharge generator having a high-voltage large-current discharge power supply, a noble metal electrode, and a counter electrode, a water tank, and a container having a water supply port for supplying water to the water tank and an outlet port for dischargin g ultrafine dispersion water of noble metal ultrafine particles, plasma discharge is caused between the noble metal electrode and the counter electrode in the water to bring the noble metal ion vapor into contact with water and to cause ultrafine dispersion. Thus, an ultrafine dispersion water of ultrafine particles containing a noble metal the concentration of which c an be adjusted can be efficiently produced by means of a small producing apparatus with high safety. The produced water is useful as health water.</S DOAB>
Patent CA-2466034-A1 (CA)
Title: Stable aqueous pharmaceutical formulations of daclizumab antibodies
Inventor: SUBRAMANIAN MALATHY
IPC: A61K47/02
Filed: 2002-11-08
Abstract: This invention is directed to a stable liquid pharmaceutical formulation comprising a high concentration, e.g. 50 mg/ml or more, of antibody in about 20-60 mM succinate buffer or 30-70 mM histidine buffer, having pH from about pH 5.5 to about pH 6.5, about 0.01-0.1 % polysorbate, and a tonicity modifie r that contributes to the isotonicity of the formulation. This liquid formulation is stable at refrigerated temperature (2-8~C) for at least 1 yea r, and preferably 2 years. This liquid formulation is suitable for subcutaneous injection. This invention is exemplified by Daclizumab, a humanized anti-IL- 2 receptor monoclonal antibody; HAIL-12, a humanized anti-IL-12 monoclonal antibody; HuEP5C7, a humanized anti-L selectin monoclonal antibody; and Flintozumab, a humanized anti-gamma interferon monoclonal antibody.
Patent CA-2467319-A1 (CA)
Title: Staggered ski skag
Inventor: DICK BRIAN W
IPC: B62B17/02
Filed: 2004-05-14
Abstract: A skag for a ski, such as a vehicle ski. The skag includes a carrier platform to be attached to the bottom surface of a ski. First and second longitudinal rails are disposed on the bottom surface of the carrier platform. The longitudinal rails are spaced apart laterally from one another. The first and second rails are staggered, such that the forward end of the first rail is farther forward than the forward end of the second rail, and the aft end of the second rail is farther aft than the aft end of the first rail. The aft end of the first rail may be at least as far forward as the forward end of the second rail. At least one of the rails may have a longitudinal keel disposed thereon, and at least one of the rails may have a hard-surface weld-disposed thereon. When two skags are used together, as on two adjacent skis, the rails and/or keels or: the skags may be arranged so that one skag is a mirror reverse of the other.
Patent CA-2468171-A1 (CA)
Title: Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
Inventor: DECOPPI PAOLO
IPC: A61K35/12
Filed: 2002-11-15
Abstract: The present invention is directed to pluripotent fetal stem cells derived from chorionic villus, amniotic fluid, and placenta and the methods for isolating, expanding and differentiating these cells, and their therapeutic uses such as manipulating the fetal stem cells by gene transfection and other means for therapeutic applications.
Patent CA-2468827-A1 (CA)
Inventor: TERASHITA ZEN-ICHI
IPC: C07D413/10
Filed: 2002-12-02
Abstract: La présente invention concerne des produits pharmaceutiques ayant une fiabilité élevée et d'excellents effets, par exemple pour améliorer l'état de résistance à l'insuline chez un grand nombre de patients souffrant de troubles associés à la résistance à l'insuline tels que le diabète. Lesdits produits pharmaceutiques sont des agents pour améliorer l'état de résistance à l'insuline, des agents pour éliminer les problèmes d'intolérance au sucre, des agents pour prévenir/traiter le diabète et l'hyperinsulinémie, etc., qui contiennent de l'acide 2-éthoxy-1-[[2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)biphényl-4-yl]méthyl]-1H-benzimidazole-7-carboxylique ou son sel.
Patent CA-2471955-A1 (CA)
Title: A nuller with no satellite signal distortion
Inventor: ASHE JEFFREY MICHAEL
IPC: H04B1/10
Filed: 2002-04-17
Abstract: Interference in a GPS receiver in minimized while preserving the GPS satellite signal in a system having N antenna elements for receiving the interference signal and the satellite signal and multiple tapped delay line structures connected to the antenna elements (160) for filtering the signals received by the antenna elements based a plurality of filter coefficients. The filter coefficients are determined such that the plurality of filter coefficients equals Rxx-1C~CHRXX-1C~-1F wherein CHW = F, where w equals the plurality of filter coefficients, Rxx equals a covariance matrix, and C and F are determined to preserve a frequency spectrum of the GPS satellite signal.
Patent CA-2472354-A1 (CA)
Inventor: GOERTZ MAGNUS GEORGE
IPC: G06F3/033
Filed: 2002-11-04
Abstract: A touch screen arrangement (1) fitted to a mobile telephone apparatus (T) and built-on or resting on a substrate (2). The touch screen includes a display unit (3) and a number of light pulse emitting units (4L) and a number of light pulse receiving units (5P), said units being edge-related to said display unit (3). The light pulse emitting units (4L) and the light pulse receiving units (5P) are orientated adjacent said display unit (3), with the directions of said emitted and received light pulses (40a, 40b) being at right angles, or at least generally at right angles, to a planar surface (3a) on the display unit (3). The touch screen also includes four light pulse deflecting devices (7, 8; 7', 8') positioned close to the display surface (3).
Patent CA-2473924-A1 (CA)
Title: Systems and methods for photodynamic therapy
Inventor: CHEN JAMES
IPC: A61K41/00
Filed: 2003-01-23
Abstract: Systems and methods for performing photodynamic therapy wherein a photoreactive agent is delivered locally and activated with an external non-invasive energy source are provided. In one embodiment, a low energy light source is used to initiate fluorescence in target tissue containing photoreactive agent. The characteristic fluorescence of the abnormal target tissue is used to generate a map that is then used to direct targeted activation energy to the target tissue without collateral damage to healthy tissue.
Patent CA-2478423-A1 (CA)
Title: Gamma secretase inhibitors
Inventor: SMITH ELIZABETH M
IPC: C07D413/12
Filed: 2003-02-05
Abstract: This invention discloses novel gamma secretase inhibitors of the formula:(Chemical formula should be inserted here as it appears on abstract in paper form)wherein: R1 is a substituted aryl or substituted heteroaryl group;  R2 is an R1 group, alkyl, -X(CO)Y, or alkylene-X(CO)Y wherein X and Y are as defined herein; each R3 and each R3A are independently H, or alkyl; R11 is aryl, heteroaryl, alkyl, cycloalkyl, arylalkyl, arylcycloalkyl, heteroarylalkyl, heteroarylcycloalkyl, arylheterocycloalkyl, or alkoxyalkyl.  Also disclosed is a method of treating Alzheimer s Disease using one or more compounds of the invention.
Patent CA-2479053-A1 (CA)
Inventor: TOLEDANO OFER
IPC: A01N25/22
Filed: 2003-03-13
Abstract: The present invention is a method of preventing crystallization of pesticida l compositions during application by adding a lactate ester as a crystallizati on preventing agent.
Patent CA-2480057-A1 (CA)
Inventor: RAJKOWSKI JANUSZ W
IPC: G09G5/00
Filed: 2003-03-28
Abstract: An apparatus and method for encoding and communicating symbols is provided. A  user encodes a symbol using a sliding motion (14 and 16) of a fingertip (10) in relation to a proximity and touch-detecting glance pad (4). The user imagines a polygon (2) on the surface of the pad. The user makes an encoding touch generally coextensive with one of the sides (8) of the polygon (2) in either a clockwise or counterclockwise direction (14 and 16). The glance pad (4) detects the motion and infers the intent of the user, assigning a symbol to the encoding touch.
Patent CA-2480984-A1 (CA)
Title: Stowable sink for a vehicle
Inventor: WARNING ANTHONY
IPC: B60R15/02
Filed: 2004-09-09
Abstract: A sink assembly for use on a vehicle that in one embodiment includes a mounting frame with an opening for mounting the sink assembly to the vehicle.  The sink assembly also includes a door that is movable relative to the mounting frame and a sink top connected to the door. The sink top has a sink bowl with a drain, and is movable between a stowed position when not in use or when the vehicle is traveling to an operational position for use of the sink assembly. The sink assembly also includes at least one attachable plumbing apparatus that is connectable to a fluid source. The sink assembly may further include a storage container for storing the plumbing apparatus when not in use or when the sink top is in the stowed position. The plumbing apparatus may include at least one of a faucet or a hose assembly.
Patent CA-2481702-A1 (CA)
Inventor: VAN SCOTT EUGENE J
IPC: A61K31/56
Filed: 2003-04-09
Abstract: La présente invention a trait à des compositions, des procédés de fabrication de telles compositions, et des procédés de traitement de troubles cosmétiques et dermatologiques avec une composition comprenant un complexe moléculaire entre l'urée et une substance fonctionnelle qui présente au moins un groupe hydroxyle et un groupe carboxyle sous la forme d'un acide libre, d'un sel, d'un amide ou d'un lactone. Les compositions sont stables par rapport aux compositions classiques contenant de l'urée, et permettent une libération contrôlée de l'urée.
Patent CA-2482185-A1 (CA)
Title: Computer, computer security setting method, and program
Inventor: OIE MASAKI
IPC: H04W12/00
Filed: 2003-04-07
Abstract: A technique for reliably changing a setting according to the usage environment to always ensure a high-security network connection environment. A PC judges the usage environment of the PC by searching for the BD addresses of nearby devices via Bluetooth and, depending on the usage environment, automatically changes the security level setting. Even when the PC is in a usage environment in which the security level should be ~home~ or ~office~ but any devices that should be in that usage environment are not detected during usage environment judgment processing, the level is set to the ~mobile~ security level at which high security is ensured.
Patent CA-2485469-A1 (CA)
Inventor: KONG DAN-CHENG
IPC: C08L51/06
Filed: 2003-04-01
Abstract: A sealable multi-layer opaque film. In particular, a sealable multi-layer opaque film that is moisture permeable and water resistant. The sealable mul ti- layer opaque film is an oriented multilayer film with a core layer comprisin g an orientation-enhancing polymer, a polypropylene homopolymer and a beta crystal nucleator of polyproplene and at least one sealable skin layer.</SDO AB>
Patent CA-2486634-A1 (CA)
Inventor: FLOETER ECKHARD
IPC: A23D7/00
Filed: 2003-05-05
Abstract: Process for the preparation of an edible triglyceride fat which is able to structure a liquid oil which process comprises the steps- selecting a triglyceride fat A and a triglyceride fat B, - interesterifying a mixture containing fat A and fat B in a ratio chosen from the range 80:20 to 20:80, where fat A is a fat which is natural and which contains at least 35 wt.% of stearic acid residues and less than 5 wt.% residues of polyunsaturated fatty acids and where fat B contains at least 40 wt.% of saturated fatty acid residues with a chain length of 12 or 14 carbon atoms and which process is characterized in that fat A is selected from the group consisting of Allanblackia fat, Pentadesma fat, Kokum fat and Sonchy fat. The resulting fat enables the preparation of a natural fat phase for use in spread manufacture.
Patent CA-2487445-A1 (CA)
Inventor: SIITONEN PEKKA
IPC: B26D7/26
Filed: 2003-05-26
Abstract: The invention relates to a blade (10) for use in the slitting of a paper or board web, comprising a hub part (11) and a blade part (15). The blade part (15) is releasably secured by means of securing members (12, 13) to the hub part (12). The securing members (12, 13) are formed so as to distribute and/ or maintain the axial load enabling the joint to withstand high circumferential speeds.
Patent CA-2488951-A1 (CA)
Title: A supporting unit for an external spare wheel
Inventor: PINO NICOLA
IPC: B62D43/04
Filed: 2004-12-03
Abstract: Described herein is a supporting unit (1) for supporting an external spare wheel (2) underneath the floor panel (3) of a motor vehicle, the unit (1) having a box-section supporting bracket (4) fixed to the floor panel (3), and a cable (6) for transmitting motion passing through the bracket (4) and provided with a first end (7) fixed to a bell (5), which can be coupled to the wheel (2), and with a second end (8) fixed to a device for recovery of the cable (6) itself; a safety assembly (35) is arranged inside the bracket (4) and is set between the first end (7) and the bell (5) to secure the bell (5) itself in a recovery position in the event of failure of the cable (6) for transmitting motion.
Patent CA-2490520-A1 (CA)
Inventor: KETCHUM JOHN W
IPC: H04L1/00
Filed: 2003-06-20
Abstract: L'invention concerne des techniques permettant de transmettre des données au moyen de plusieurs modes de transmission en diversité afin d'améliorer la fiabilité. Au niveau de l'émetteur, pour chacun du ou des flux de données, un mode de transmission particulier est sélectionné parmi plusieurs modes de transmission possibles. Ces modes de transmission peuvent comprendre un mode de transmission en diversité de fréquence, un mode de transmission en diversité de Walsh, un mode de transmission en diversité de transmission temporelle et spatiale (STTD), un mode de transmission Walsh-STTD. Chaque mode de transmission en diversité transmet de manière redondante des données sur une période temporelle, une fréquence, un espace ou une combinaison de ceux-ci. Chaque flux de données est codé puis modulé de manière à obtenir des symboles de modulation, lesquels sont, par la suite, traités en fonction du mode de transmission en diversité sélectionné afin d'obtenir des symboles d'émission. Pour le multiplexage par répartition orthogonale de la fréquence, les symboles d'émission destinés à tous les flux de données sont modulés par OFDM une nouvelle fois de manière à obtenir un flux de symboles de transmission pour chaque antenne émettrice utilisée pour la transmission de données.
Patent CA-2492295-A1 (CA)
Title: Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
Inventor: SCADDEN DAVID T
IPC: C12N5/02
Filed: 2003-07-25
Abstract: The invention relates to methods for manipulating hematopoietic progenitor cells and related products. In one aspect the invention relates to the use of agents that activate a PTH/PTHrP receptor to enhance the growth and maintenance of hematopoietic progenitor cells in vivo and in vitro, to enhance mobilization of hematopoietic stem cells, to improve the efficiency of targeting cells to the bone marrow, and/or to modulate hematopoietic progenitor cell function.
Patent CA-2493531-A1 (CA)
Title: History based measured power control response
Inventor: DICKSON SCOTT
IPC: H04B7/005
Filed: 2003-07-23
Abstract: Frames received on a first link of a channel are grouped or queued for later processing in a batch or batch mode. Power control instructions included wit h the frames are examined, and a history of predetermined length is kept. Fram es to be transmitted on a second link of the channel are also batched for later handling in batch. Power control bits are generated for the frames, based at least in part on the history kept, in a manner that effectuates a slowing of responding to the incoming power control instructions.